Categories

Counsyl, Inc. has combined with Myriad Genetics’ Preventive Care business unit to form Myriad Women’s Health, Inc., a premier genetic screening…

Continue Reading

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can…

Continue Reading

According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime.  In…

Continue Reading

September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer…

Continue Reading

The biomedical innovation now happening in the molecular diagnostics industry is making it possible for clinicians to answer their patients’ four…

Continue Reading

Mental Health Month, Depression and GeneSight®    The GeneSight® genetic test has produced exciting news for patients diagnosed with depression.  A landmark…

Continue Reading

ColonCancerPoster_Thumbnail

In hereditary colon cancer, knowledge is power!  During the month of March, Myriad Genetics is demonstrating a strong commitment to preventing hereditary colon…

Continue Reading

The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic…

Continue Reading

It is estimated that 19 million people suffer from “year round” depression. If every American with depression lived in one state…

Continue Reading

Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29…

Continue Reading